Key result
Inhibiting the mitochondrial Na+/Ca2+ exchanger with CGP-37157 prevented the impaired NADH response and enhanced mitochondrial Ca2+ accumulation in heart failure myocytes with high cytosolic Na+.
Why the study?
Does inhibiting the mitochondrial Na+/Ca2+ exchanger improve mitochondrial bioenergetics in heart failure myocytes?
Does inhibiting the mitochondrial Na+/Ca2+ exchanger improve mitochondrial bioenergetics in heart failure myocytes?
Inhibiting the mitochondrial Na+/Ca2+ exchanger prevents impaired NADH response and improves mitochondrial bioenergetics in heart failure myocytes with elevated cytosolic Na+.
Hypothesis-generating for mNCX inhibition in HF bioenergetics; in vivo validation required before clinical translation.
Mitochondrial ATP production is continually adjusted to energy demand through coordinated increases in oxidative phosphorylation and NADH production mediated by mitochondrial Ca2+([Ca2+]m). Elevated cytosolic Na+ impairs [Ca2+]m accumulation during rapid pacing of myocytes, resulting in a decrease in NADH/NAD+ redox potential. Here, we determined 1) if accentuating [Ca2+]m accumulation prevents the impaired NADH response at high [Na+]i; 2) if [Ca2+]m handling and NADH/NAD+ balance during stimulation is impaired with heart failure (induced by aortic constriction); and 3) if inhibiting [Ca2+]m efflux improves NADH/NAD+ balance in heart failure. [Ca2+]m and NADH were recorded in cells at rest and during voltage clamp stimulation (4Hz) with either 5 or 15 mmol/L [Na+]i. Fast [Ca2+]m transients and a rise in diastolic [Ca2+]m were observed during electric stimulation. [Ca2+]m accumulation was [Na+]i-dependent; less [Ca2+]m accumulated in cells with 15 Na+ versus 5 mmol/L Na+ and NADH oxidation was evident at 15 mmol/L Na+, but not at 5 mmol/L Na+. Treatment with either the mitochondrial Na+/Ca2+ exchange inhibitor CGP-37157 (1 micromol/L) or raising cytosolic Pi (2 mmol/L) enhanced [Ca2+]m accumulation and prevented the NADH oxidation at 15 mmol/L [Na+]i. In heart failure myocytes, resting [Na+]i increased from 5.2+/-1.4 to 16.8+/-3.1mmol/L and net NADH oxidation was observed during pacing, whereas NADH was well matched in controls. Treatment with CGP-37157 or lowering [Na+]i prevented the impaired NADH response in heart failure. We conclude that high [Na+]i (at levels observed in heart failure) has detrimental effects on mitochondrial bioenergetics, and this impairment can be prevented by inhibiting the mitochondrial Na+/Ca2+ exchanger.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2008) studied Heart failure. CGP-37157 (mitochondrial Na+/Ca2+ exchange inhibitor) vs. Control (high [Na+]i without inhibitor) was evaluated on Mitochondrial Ca2+ accumulation and NADH/NAD+ balance during pacing. Inhibiting the mitochondrial Na+/Ca2+ exchanger with CGP-37157 prevented the impaired NADH response and enhanced mitochondrial Ca2+ accumulation in heart failure myocytes with high cytosolic Na+.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: